Various key players in regulating AD, including APP, tau protein, BACE1, and the γ-secretase subunit nicastrin are modulated by glycosylation, and the glycosylation pattern of these proteins is also altered in AD. This evidence concerns the gene BACE1 and Alzheimer disease.